Financials in USD. Standardized financial statements.
A compact view of how Lucira Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|
| Revenue? | $93.06M | $269,000 | $0 | $0 |
| Revenue Growth? | +34492.9% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $82.83M | $1.94M | $0 | $0 |
| Gross Profit? | $10.22M | -$1.67M | $0 | $0 |
| Gross Margin? | +11.0% | -621.6% | 0.0% | 0.0% |
| Operating Expenses? | $74.76M | $28.11M | $7.70M | $6.16M |
| Operating Income? | -$64.54M | -$31.93M | -$13.86M | -$9.81M |
| EBITDA? | -$60.52M | -$29.50M | -$7.42M | -$5.91M |
| Income Before Tax | -$64.81M | -$37.35M | -$8.47M | -$6.54M |
| Income Tax Expense | $17,000 | $53,000 | $90,000 | $190,000 |
| Net Income? | -$64.83M | -$37.40M | -$8.56M | -$6.73M |
| EPS? | $-1.86 | $-1.04 | $-0.56 | $-0.44 |
| Diluted EPS? | $-1.86 | $-1.04 | $-0.56 | $-0.44 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality